N4 Pharma

(N4P)
Sector: Pharmaceuticals & Biotechnology
0.63p
-0.02p -2.56
Last updated: 11:00:06

Director dealings

Trade date Director Volume / Price Trade value Trade type
28/05/2019 Luke Cairns 0 @ 0.00 0.00 Notification of Holding
10/04/2019 Nigel Theobald 67,343 @ 44.40p £29,900.29 Buy
10/04/2019 Nigel Theobald 67,343 @ 4.44p £2,990.03 Buy
10/11/2017 Nigel Theobald 56,656 @ 7.92p £4,487.16 Buy
14/10/2015 Gavin John Burnell 0 @ 0.00 0.00 Notification of Holding
19/05/2011 Humayun Akhter Mughal 0 @ 0.00 0.00 Notification of Holding

Director shareholdings

Name Holding Percent
Nigel Theobald 12,389,919 16.00%
Luke Cairns 142,660 0.00%

Major shareholders

Institution name Holding Percent
Mathenz Marc Kay 33,000,000 8.36%
NIGEL JAMES THEOBALD 16,981,319 4.30%
Peel Hunt LLP 7,436,152 10.37%
Lynchwood Nominees Limited 690,800 10.00%
Barclays Stockbrokers Limited 447,800 6.49%
LR Nominees Limited 311,600 4.51%